- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.30 Å
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 20 x PGW: (1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate(Non-covalent)
PGW.2: 9 residues within 4Å:- Chain B: P.395, D.396, F.398, W.399, V.402
- Chain H: I.418, K.421, I.422, S.425
4 PLIP interactions:2 interactions with chain H, 2 interactions with chain B- Hydrogen bonds: H:K.421, H:K.421
- Hydrophobic interactions: B:F.398, B:V.402
PGW.3: 1 residues within 4Å:- Chain B: I.331
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:I.331
PGW.4: 2 residues within 4Å:- Chain H: G.419, I.422
1 PLIP interactions:1 interactions with chain H- Hydrophobic interactions: H:I.422
PGW.5: 2 residues within 4Å:- Chain B: L.350
- Chain H: T.434
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:L.350
PGW.6: 7 residues within 4Å:- Chain B: Q.251, S.252, T.253, F.260, T.264, Y.303, E.311
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:F.260, B:T.264
PGW.12: 9 residues within 4Å:- Chain D: P.395, D.396, F.398, W.399, V.402
- Chain F: I.418, K.421, I.422, S.425
4 PLIP interactions:2 interactions with chain F, 2 interactions with chain D- Hydrogen bonds: F:K.421, F:K.421
- Hydrophobic interactions: D:F.398, D:V.402
PGW.13: 1 residues within 4Å:- Chain D: I.331
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:I.331
PGW.14: 2 residues within 4Å:- Chain F: G.419, I.422
1 PLIP interactions:1 interactions with chain F- Hydrophobic interactions: F:I.422
PGW.15: 2 residues within 4Å:- Chain D: L.350
- Chain F: T.434
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:L.350
PGW.16: 7 residues within 4Å:- Chain D: Q.251, S.252, T.253, F.260, T.264, Y.303, E.311
2 PLIP interactions:2 interactions with chain D- Hydrophobic interactions: D:F.260, D:T.264
PGW.22: 9 residues within 4Å:- Chain B: I.418, K.421, I.422, S.425
- Chain F: P.395, D.396, F.398, W.399, V.402
4 PLIP interactions:2 interactions with chain F, 2 interactions with chain B- Hydrophobic interactions: F:F.398, F:V.402
- Hydrogen bonds: B:K.421, B:K.421
PGW.23: 1 residues within 4Å:- Chain F: I.331
1 PLIP interactions:1 interactions with chain F- Hydrophobic interactions: F:I.331
PGW.24: 2 residues within 4Å:- Chain B: G.419, I.422
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:I.422
PGW.25: 2 residues within 4Å:- Chain B: T.434
- Chain F: L.350
1 PLIP interactions:1 interactions with chain F- Hydrophobic interactions: F:L.350
PGW.26: 7 residues within 4Å:- Chain F: Q.251, S.252, T.253, F.260, T.264, Y.303, E.311
2 PLIP interactions:2 interactions with chain F- Hydrophobic interactions: F:F.260, F:T.264
PGW.32: 9 residues within 4Å:- Chain D: I.418, K.421, I.422, S.425
- Chain H: P.395, D.396, F.398, W.399, V.402
4 PLIP interactions:2 interactions with chain D, 2 interactions with chain H- Hydrogen bonds: D:K.421, D:K.421
- Hydrophobic interactions: H:F.398, H:V.402
PGW.33: 1 residues within 4Å:- Chain H: I.331
1 PLIP interactions:1 interactions with chain H- Hydrophobic interactions: H:I.331
PGW.34: 2 residues within 4Å:- Chain D: G.419, I.422
1 PLIP interactions:1 interactions with chain D- Hydrophobic interactions: D:I.422
PGW.35: 2 residues within 4Å:- Chain D: T.434
- Chain H: L.350
1 PLIP interactions:1 interactions with chain H- Hydrophobic interactions: H:L.350
PGW.36: 7 residues within 4Å:- Chain H: Q.251, S.252, T.253, F.260, T.264, Y.303, E.311
2 PLIP interactions:2 interactions with chain H- Hydrophobic interactions: H:F.260, H:T.264
- 16 x K: POTASSIUM ION(Non-covalent)(Non-functional Binders)
K.7: 15 residues within 4Å:- Chain B: V.408, G.409
- Chain D: V.408, G.409
- Chain F: V.408, G.409
- Chain H: V.408, G.409
- Ligands: K.8, K.17, K.18, K.27, K.28, K.37, K.38
Ligand excluded by PLIPK.8: 19 residues within 4Å:- Chain B: T.407, V.408
- Chain D: T.407, V.408
- Chain F: T.407, V.408
- Chain H: T.407, V.408
- Ligands: K.7, K.9, K.17, K.18, K.19, K.27, K.28, K.29, K.37, K.38, K.39
Ligand excluded by PLIPK.9: 11 residues within 4Å:- Chain B: T.407
- Chain D: T.407
- Chain F: T.407
- Chain H: T.407
- Ligands: K.8, K.18, K.19, K.28, K.29, K.38, K.39
Ligand excluded by PLIPK.10: 3 residues within 4Å:- Ligands: K.20, K.30, K.40
Ligand excluded by PLIPK.17: 15 residues within 4Å:- Chain B: V.408, G.409
- Chain D: V.408, G.409
- Chain F: V.408, G.409
- Chain H: V.408, G.409
- Ligands: K.7, K.8, K.18, K.27, K.28, K.37, K.38
Ligand excluded by PLIPK.18: 19 residues within 4Å:- Chain B: T.407, V.408
- Chain D: T.407, V.408
- Chain F: T.407, V.408
- Chain H: T.407, V.408
- Ligands: K.7, K.8, K.9, K.17, K.19, K.27, K.28, K.29, K.37, K.38, K.39
Ligand excluded by PLIPK.19: 11 residues within 4Å:- Chain B: T.407
- Chain D: T.407
- Chain F: T.407
- Chain H: T.407
- Ligands: K.8, K.9, K.18, K.28, K.29, K.38, K.39
Ligand excluded by PLIPK.20: 3 residues within 4Å:- Ligands: K.10, K.30, K.40
Ligand excluded by PLIPK.27: 15 residues within 4Å:- Chain B: V.408, G.409
- Chain D: V.408, G.409
- Chain F: V.408, G.409
- Chain H: V.408, G.409
- Ligands: K.7, K.8, K.17, K.18, K.28, K.37, K.38
Ligand excluded by PLIPK.28: 19 residues within 4Å:- Chain B: T.407, V.408
- Chain D: T.407, V.408
- Chain F: T.407, V.408
- Chain H: T.407, V.408
- Ligands: K.7, K.8, K.9, K.17, K.18, K.19, K.27, K.29, K.37, K.38, K.39
Ligand excluded by PLIPK.29: 11 residues within 4Å:- Chain B: T.407
- Chain D: T.407
- Chain F: T.407
- Chain H: T.407
- Ligands: K.8, K.9, K.18, K.19, K.28, K.38, K.39
Ligand excluded by PLIPK.30: 3 residues within 4Å:- Ligands: K.10, K.20, K.40
Ligand excluded by PLIPK.37: 15 residues within 4Å:- Chain B: V.408, G.409
- Chain D: V.408, G.409
- Chain F: V.408, G.409
- Chain H: V.408, G.409
- Ligands: K.7, K.8, K.17, K.18, K.27, K.28, K.38
Ligand excluded by PLIPK.38: 19 residues within 4Å:- Chain B: T.407, V.408
- Chain D: T.407, V.408
- Chain F: T.407, V.408
- Chain H: T.407, V.408
- Ligands: K.7, K.8, K.9, K.17, K.18, K.19, K.27, K.28, K.29, K.37, K.39
Ligand excluded by PLIPK.39: 11 residues within 4Å:- Chain B: T.407
- Chain D: T.407
- Chain F: T.407
- Chain H: T.407
- Ligands: K.8, K.9, K.18, K.19, K.28, K.29, K.38
Ligand excluded by PLIPK.40: 3 residues within 4Å:- Ligands: K.10, K.20, K.30
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pau, V. et al., Crystal structure of an inactivated mutant mammalian voltage-gated K(+) channel. Nat. Struct. Mol. Biol. (2017)
- Release Date
- 2017-08-30
- Peptides
- Voltage-gated potassium channel subunit beta-2: ACEG
Potassium voltage-gated channel subfamily A member 2,Potassium voltage-gated channel subfamily A member 2: BDFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AG
AB
BD
BF
BH
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.30 Å
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 20 x PGW: (1R)-2-{[(S)-{[(2S)-2,3-dihydroxypropyl]oxy}(hydroxy)phosphoryl]oxy}-1-[(hexadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate(Non-covalent)
- 16 x K: POTASSIUM ION(Non-covalent)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pau, V. et al., Crystal structure of an inactivated mutant mammalian voltage-gated K(+) channel. Nat. Struct. Mol. Biol. (2017)
- Release Date
- 2017-08-30
- Peptides
- Voltage-gated potassium channel subunit beta-2: ACEG
Potassium voltage-gated channel subfamily A member 2,Potassium voltage-gated channel subfamily A member 2: BDFH - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AG
AB
BD
BF
BH
B - Membrane
-
We predict this structure to be a membrane protein.